col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


94 Ergebisse       Seite 1

 [1] 
Elsevier: Journal of Clinical Virology Plus
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Jan―19 The New Normal Post Emergence of SARS-CoV-2 Catherine Moore
2 [GO] 2023―Dez―21 Comparison of the incidence of severe outcomes in outpatients with COVID-19 or seasonal influenza without risk factors: retrospective analysis of a health insurance claims-database H. Oshitani, T. Komeda, S. Fujita, M. Asakawa, Y. Kitanishi
3 [GO] 2023―Okt―17 Evaluation of the Clinical Performance of BD SARS-CoV-2 Flu Assay for BD COR™ System Elizabeth Lockamy, Rebekah M. Martin, Jordan Ippolito
4 [GO] 2023―Okt―14 SARS-CoV-2 and chronic hepatitis B: focusing on the possible consequences of co-infection Shahrzad Shoraka, Seyed Reza Mohebbi, Seyed Masoud Hosseini, Amir Ghaemi, Mohammad Reza Zali
5 [GO] 2023―Okt―10 Comparative evaluation of SARS-CoV-2 serological tests shows significant variability in performance across different years of infection and between the tests Dell-Dylan Kenfack, Georges Ngk-Tsague, Veronique B Penlap, Martin F Maidadi, Celestin Godwe, Nico F Njayou, et al. (+4)
6 [GO] 2023―Okt―05 Viral load in symptomatic and asymptomatic patients infected with SARS-CoV-2. What have we learned? Marina Mozgovoj, Merceder Dieder Graham, Cecilia Ferrufino, Sofia Blanc, Adriana Fernandez Souto, Marcela Pillof, Maria Jose Dus Santos
7 [GO] 2023―Sep―19 Post-infectious Neurological Complications of COVID-19- A tertiary care centre experience S.M Krishna Mohan M, Asish Vijayaraghavan, Soumya Sundaram, Sruthi S Nair, Sajith Sukumaran
8 [GO] 2023―Sep―03 Exposure factors associated with SARS-CoV-2 seropositivity are not predictive for higher humoral immune responses: a cross-sectional cohort study in the general population D.A.T. Hanssen, D.M.E. Pagen, J. Penders, S. Brinkhues, N.H.T.M. Dukers-Muijrers, C.J.P.A. Hoebe, et al. (+2)
9 [GO] 2023―Aug―09 One Pediatrician's Battle with COVID-19 and Acute Liver Failure Pooya Farhangnia, Amir Reza Safdarian, Shamim Mollazadeh Ghomi, Shabnam Mollazadehghomi, Ali-Akbar Delbandi
10 [GO] 2023―Jul―18 Performance of self-collected saliva samples for SARS-CoV-2 mass testing in community settings Olivia Kay, Matthias E Futschik, Elena Turek, David Chapman, Simon Carr, Malur Sudhanva, et al. (+9)
11 [GO] 2023―Jul―01 SARS-CoV-2 Antibody Response Duration and Neutralization Following Natural Infection Christopher W Dukes, Renata AM Rossetti, Jonathan A Hensel, Sebastian Snedal, Christopher L Cubitt, Michael J Schell, et al. (+13)
12 [GO] 2023―Jun―30 High concordance of the TaqMan SARS-CoV-2 mutation panel and spike gene sequencing for the detection of SARS-COV-2 Variants Of Concern Paul Alain Tagnouokam-Ngoupo, Chavely Gwladys Monamele, Serge Alain Sadeuh-Mba, Jules Brice Tchatchueng Mbougua, Estelle Madaha Longla, Njei Abanda Ngu, et al. (+5)
13 [GO] 2023―Jun―28 Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations Thomas Perkmann, David N. Springer, Patrick Mucher, Michael Wolzt, Lukas Weseslindtner, Helmuth Haslacher
14 [GO] 2023―Jun―25 High SARS-CoV-2 seroprevalence in Lagos, Nigeria with Robust Antibody and Cellular Immune Responses Sulaimon Akanmu, Bobby Brooke Herrera, Beth Chaplin, Sade Ogunsola, Akin Osibogun, Fatima Onawoga, et al. (+6)
15 [GO] 2023―Mai―24 ANALYSIS OF SARS-CoV-2 SUBLINEAGES REPORTED FROM LOCAL CASES IN MAINLAND CHINA (SEPTEMBER 2022-JANUARY 2023) AND SURVEILLANCE OF OUTBOUND PASSENGERS. Daniele Focosi, Federico Gueli, Cesare Gruber, Emanuela Giombini, Fabrizio Maggi
16 [GO] 2023―Mai―12 When rare becomes common: N2 gene-positive, E gene-negative SARS-CoV-2 PCR results between 2021 and 2022 Frank Bernhard Kraus, Stefan Moritz, Könül Mamadova, Mario Popp, Marija Kocijancic, Beatrice Ludwig-Kraus
17 [GO] 2023―Mai―10 Clinical study to compare the Efficacy and Safety of casirivimab & imdevimab, Remdesivir, and Favipravir in hospitalized COVID-19 patients Ahmed H. Hassan, Sahar K. Hegazy, Samar T. Radwan
18 [GO] 2023―Apr―22 SARS-CoV-2 evolution during persistent infection in a CAR-T recipient shows an escape to both sotrovimab and T-cell responses Paola Mazzetti, Pietro Giorgio Spezia, Anna Lisa Capria, Giulia Freer, Maria Sidoti, Silvia Costarelli, et al. (+12)
19 [GO] 2023―Apr―07 COVID-19-induced headache in Boston and the vicinity Bart K. Chwalisz, Vi K. Le, Jennifer R. Cheng, Aayushee Jain, M. Brandon Westover, Hsinlin T. Cheng
20 [GO] 2023―Mrz―28 Comparison of Real-time RT-PCR cycle threshold (Ct) values with clinical features and severity of COVID-19 disease among hospitalized patients in the first and second waves of COVID-19 pandemic in Chennai, India Sudhakar Natarajan, Mohan Ranganathan, P L Natarajan, Manohar Nesakumar, S Anbalagan, K Lucia Precilla, et al. (+8)
21 [GO] 2023―Mrz―09 COVID or no COVID: interpreting inconclusive SARS-CoV-2 qPCR results in different populations and platforms Christien Rondaan, Lilli Gard, Prof. Hubert G.M. Niesters, Coretta van Leer-Buter, Xuewei Zhou
22 [GO] 2023―Jan―27 Reverse transcription-loop-mediated isothermal amplification (RT-LAMP) assay as a rapid molecular diagnostic tool for COVID-19 in healthcare workers Victor dos Santos Barboza, William Borges Domingues, Thobias Toniolo de Souza, Tiago Veiras Collares, Fabiana Kommling Seixas, Bruna Silveira Pacheco, et al. (+7)
23 [GO] 2023―Jan―21 Measles Surveillance: Lessons from the COVID-19 Pandemic Noosha Samieefar, SeyedehFatemeh Mousavi, Hediyeh Baghsheikhi, Fahimeh Abdollahimajd
24 [GO] 2023―Jan―18 Accuracy of an antigen-detecting SARS-CoV-2 assay with self- and provider-collected specimens interpreted visually and with BD Veritor™ Plus analyzer Lauren Cooper, Karen Eckert, Joseph Mann, Rossmeri Montalvo, Luis Castillo, Dwan Fellows, Stephen Young
25 [GO] 2023―Jan―13 Analytical and clinical performances of seven direct detection assays for SARS-CoV-2 Yasufumi Matsumura, Wataru Yamazaki, Taro Noguchi, Masaki Yamamoto, Miki Nagao
26 [GO] 2023―Jan―13 Comparison of one single-antigen assay and three multi-antigen SARS-CoV-2 IgG assays in Nigeria Nnaemeka C. Iriemenam, Fehintola A. Ige, Stacie M. Greby, Olumide O. Okunoye, Mabel Uwandu, Maureen Aniedobe, et al. (+21)
27 [GO] 2023―Jan―11 A simple point-of-care assay accurately detects anti-spike antibodies after SARS-CoV-2 vaccination Sarah E. Greene, Yuefang Huang, Wooseob Kim, Mariel J. Liebeskind, Vinay Chandrasekaran, Zhuoming Liu, et al. (+13)
28 [GO] 2022―Dez―29 Evaluation of Loop-Mediated Isothermal Amplification for Detecting COVID-19 Astuti Giantini, Muhammad Suhaeri, Ardiana Kusumaningrum, Dimas Seto Prasetyo, Windy Sahar, Rakhmad Hidayat, Muhammad Arza Putra
29 [GO] 2022―Dez―29 Clinical assessment of SARS-CoV-2 infectivity by rapid antigen test compared with virus isolation Tai-Ling Chao, Wen-Hau Lee, Hui-Chun Hu, Yi-Chun Lin, Shu-Yuan Ho, Hui-Hou Chen, et al. (+9)
30 [GO] 2022―Dez―18 Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) Serology in the Vaccination Era and Post Booster Vaccination Latha Dulipsingh, Maxine Lang, Margaret R. Diffenderfer, Lisa Cook, Jennifer Puff, Lynn Diaz, et al. (+2)
31 [GO] 2022―Dez―13 Evaluation of STANDARD M10 SARS-CoV-2 assay as a diagnostic tool for SARS-CoV-2 in nasopharyngeal or oropharyngeal swab samples Maria-Eleni Parakatselaki, Georgia Alexi, Alexandros Zafiropoulos, George Sourvinos
32 [GO] 2022―Dez―06 Convalescent plasma for COVID-19 in oncohematological patients: a call for revision of the European Conference on Infections in Leukemia-9 guidelines. Daniele Focosi, Massimo Franchini, Jonathon W. Senefeld, Arturo Casadevall, Michael J. Joyner
33 [GO] 2022―Nov―17 Prevalence of SARS-CoV-2 Antibodies after the Omicron Surge, Kingston, Jamaica, 2022 Joshua J. Anzinger, Suzette M. Cameron-McDermott, Yakima Z.R. Phillips, Leshawn Mendoza, Mark Anderson, Gavin Cloherty, et al. (+3)
34 [GO] 2022―Nov―04 IgA quantification as a good predictor of the neutralizing antibodies levels after vaccination against SARS-CoV-2 Lorena O. Fernandes-Siqueira, Bruna G. Sousa, Carlos E. Cleto, Luciana S. Wermelinger, Beatriz L.L. Caetano, Agatha R. Pacheco, et al. (+6)
35 [GO] 2022―Okt―18 Mini-evaluation of the Lyra SARS-CoV-2 assay to detect Omicron BA.1 and BA.2 in nasopharyngeal swabs Tung Phan, Stephanie Boes, Melissa McCullough, Jamie Gribschaw, Alan Wells
36 [GO] 2022―Okt―08 Rapid detection of human coronavirus NL63 by isothermal reverse transcription recombinase polymerase amplification Aline Dorendorf, Iris Bachmann, Martin Spiegel, Ahmed Abd El Wahed, Gregory Dame, Frank Hufert
37 [GO] 2022―Sep―16 Dynamics of SARS-CoV-2 exposure in Malawian infants between February 2020 and May 2021 Silvia Baroncelli, Clementina Maria Galluzzo, Stefano Orlando, Robert Mphwere, Thom Kavalo, Richard Luhanga, et al. (+6)
38 [GO] 2022―Sep―13 Clinical performance of SARS-CoV-2 detection on the cobas Liat using water gargle samples Maxime Veillette, Francine Tourangeau, Judith Fafard, Jeannot Dumaresq, Annie-Claude Labbé
39 [GO] 2022―Sep―13 SARS-CoV-2 Omicron detection by antigen tests using saliva Kaoru Murakami, Sumio Iwasaki, Satoshi Oguri, Kumiko Tanaka, Rigel Suzuki, Kasumi Hayasaka, et al. (+7)
40 [GO] 2022―Aug―22 Emergence and evolution of SARS-CoV-2 genetic variants during the Cuban epidemic. María G Guzmán, Lissette Pérez, Yahisel Tejero, Dailyn Mederos, Mirtha E. Aguado, Yanet Pintos, et al. (+12)
41 [GO] 2022―Aug―17 DEVELOPMENT AND VALIDATION OF AN ENZYME-LINKED IMMUNOASSAY KIT FOR DIAGNOSIS AND SURVEILLANCE OF COVID-19 Flávia F. Bagno, Sarah A.R. Sérgio, Maria Marta Figueiredo, Lara C. Godoi, Luis A.F. Andrade, Natália C. Salazar, et al. (+10)
42 [GO] 2022―Aug―06 DEVELOPMENT AND VALIDATION OF AN ENZYME-LINKED IMMUNOASSAY KIT FOR DIAGNOSIS AND SURVEILLANCE OF COVID-19 Flávia F. Bagno, Sarah A.R. Sérgio, Maria Marta Figueiredo, Lara C. Godoi, Luis A.F. Andrade, Natália C. Salazar, et al. (+10)
43 [GO] 2022―Jul―23 Follow-up COVID-19 PCR result up to day 5 with clinical features predicts positivity for inconclusive results Sung-Soo Park, Duck-Jin Hong, Katrine K Gatchalian, Hye-Young Oh
44 [GO] 2022―Jul―21 Clinical Comparison and Agreement of PCR, Antigen, and viral culture for the diagnosis of COVID-19 Amanda Agard, Omar Elsheikh, Drew Bell, Ryan Relich, Bryan Schmitt, Josh Sadowski, et al. (+8)
45 [GO] 2022―Jul―16 Evaluation of the artus® Prep&Amp UM RT-PCR for detection of SARS-CoV-2 from nasopharyngeal swabs without prior nucleic acid eluate extraction Robert William O'Hara, Benjamin Brown, Angela Hughes, Ashley McEwan, Andrew Birtles, Adam Hawker, et al. (+10)
46 [GO] 2022―Jun―30 ANTIBODY RESPONSE AFTER A BOOSTER DOSE OF BNT162B2mRNA AND INACTIVATED COVID-19 VACCINE Metin Yigit, Aslinur Ozkaya-Parlakay, Yasemin Cosgun, Yunus Emre Ince, Furkan Kalayci, Naci Yilmaz, Emrah Senel
47 [GO] 2022―Jun―28 SOTROVIMAB-EMERGENT RESISTANCE IN SARS-CoV-2 OMICRON: A SERIES OF THREE CASES. Daniele Focosi, Federica Novazzi, Andreina Baj, Francesca Drago Ferrante, Sara Boutahar, Angelo Paolo Genoni, et al. (+2)
48 [GO] 2022―Jun―26 Evaluation of the DiaSorin LIAISON SARS-CoV-2 antigen assay on nasopharyngeal swabs in two different SARS-CoV-2 pandemic waves in Switzerland: The impact of the Omicron variant on its performance Stephanie Uster, Zana Topalli, Thomas Sasse, Franziska Suter-Riniker, Maria Teresa Barbani
49 [GO] 2022―Jun―24 Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infection Beth Catlett, Mitchell Starr, Dorothy A Machalek, Thidarat Danwilai, Michael Palmer, Andrew Kelly, et al. (+5)
50 [GO] 2022―Jun―20 Antibodies against SARS-CoV-2 after natural infection in healthcare workers and clinical characteristics as putative antibody production prediction D.A.T. Hanssen, J. Penders, K. Heijgele, S. de Leede, M. Mulder, L.E.A. Bank, et al. (+3)
51 [GO] 2022―Jun―17 Detection of SARS-CoV-2 VOC-Omicron using commercial sample-to-answer real-time RT-PCR platforms and melting curve-based SNP assays Brian H M Sit, Kathy Hiu Laam Po, Yuk-Yam Cheung, Alan K L Tsang, Patricia K L Leung, J Zheng, et al. (+4)
52 [GO] 2022―Jun―07 From Delta to Omicron SARS-CoV-2 variant: Switch to saliva sampling for higher detection rate Margot Cornette, Bieke Decaesteker, Geert Antoine Martens, Patricia Vandecandelaere, Stijn Jonckheere
53 [GO] 2022―Mai―21 SARS-CoV-2 RECOMBINANT XN, ITALY Federica Novazzi, Daniele Focosi, Andreina Baj, Andrea Ambrosini, Sara Bouthar, Fabrizio Maggi
54 [GO] 2022―Mai―21 Comparing COVID-19 PCR positivity duration for Omicron vs earlier variants Kojima N, Roshani A, Klausner JD
55 [GO] 2022―Mai―04 Development and performance of a point-of-care rapid antigen test for detection of SARS-COV-2 variants Lihong Liu, Kathrine Meyers, Lawrence J. Purpura, Nadia Nguyen, Hiroshi Mohri, Jennifer Y. Chang, et al. (+27)
56 [GO] 2022―Mrz―01 Evaluation of the ePlex Respiratory Pathogen Panel 2 to detect viral and bacterial pathogens, including SARS-CoV-2 Omicron in nasopharyngeal swabs Tung Phan, Pamela Valeriano, Stephanie Boes, Melissa McCullough, Jamie Gribschaw, Alan Wells
57 [GO] 2022―Feb―22 Factors Associated with Death and ICU Referral among COVID-19 Patients Hospitalized in the Secondary Referral Academic Hospital in East Jakarta, Indonesia Yessi Setianegari, Linggom Kurniaty, Danny E.J. Luhulima, Bambang S.R. Utomo, Louisa A. Langi, Evy S. Arodes, et al. (+3)
58 [GO] 2022―Feb―19 Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 test for bronchoalveolar lavage Tung Phan, Ashley Mays, Melissa McCullough, Alan Wells
59 [GO] 2022―Jan―15 Fast and reliable real life data on COVID-19 triaging with ID NOW Elisa Burdino, Francesco Cerutti, Maria Grazia Milia, Tiziano Allice, Gabriella Gregori, Franco Aprà, et al. (+4)
60 [GO] 2022―Jan―11 Humoral cross-reactivity towards SARS-CoV-2 in young children with acute respiratory infection with low-pathogenicity coronaviruses Nitin Dhochak, Tanvi Agrawal, Heena Shaman, Naseem Ahmed Khan, Prawin Kumar, Sushil K. Kabra, et al. (+2)
61 [GO] 2022―Jan―10 Case series of HIV SARS-CoV-2 co-infection in Chinese adults Rita Wai-Yin Ng, Chun-Kwok Wong, Grace Chung-Yan Lui, Eugene Yuk-Keung Tso, Zigui Chen, Owen Tak-Yin Tsang, et al. (+8)
62 [GO] 2021―Dez―22 The incidence of infectious diseases and viruses other than SARS-CoV-2 among hospitalised children in Oslo, Norway during the Covid-19 pandemic 2020-2021 Per Kristian Knudsen, Andreas Lind, Ingvild Klundby, Susanne Dudman
63 [GO] 2021―Dez―16 SARS-CoV-2 loads in urine, sera and stool specimens in association with clinical features of COVID-19 patients Déborah Anjos, Fabiola Souza Fiaccadori, Carolina do Prado Servian, Simone Gonçalves da Fonseca, Adriana Oliveira Guilarde, Moara Alves Santa Bárbara Borges, et al. (+3)
64 [GO] 2021―Dez―08 Borderline and weakly positive antibody levels against the S-protein of SARS-CoV-2 exhibit limited agreement with virus neutralization titres Alexander E. Egger, Christian Irsara, Barbara Holzer, Christoph Winkler, Rosa Bellmann-Weiler, Günter Weiss, et al. (+5)
65 [GO] 2021―Nov―14 SARS-CoV-2 Seroprevalence Rates of Children Seeking Medical Care in Louisiana During the State Stay at Home Order Monika L. Dietrich, Elizabeth B. Norton, Debra Elliott, Ashley R. Smira, Ofek Raviv, Daniel J. Sasson, et al. (+21)
66 [GO] 2021―Nov―11 Nosocomial infections among critically ill COVID-19 patients in Australia Mahesh Ramanan, Aidan Burrell, Eldho Paul, Tony Trapani, Tessa Broadley, Steve McGloughlin, et al. (+2)
67 [GO] 2021―Nov―08 Retrospective epidemiology of the SARS-CoV-2 (and COVID-19) epidemic among 27 Brazilian cities Sandra Souza Lima, Maria Alice Freitas Queiroz, Luiz Fernando Almeida Machado, Antonio Carlos Rosário Vallinoto, Marluísa de Oliveira Guimarães Ishak, Ricardo Ishak
68 [GO] 2021―Okt―13 Trends in SARS-CoV-2 seroprevalence among urban paediatric patients compared with a nationwide cohort in the Netherlands I.L.M. Rotee, D.S.Y. Ong, J.G.M. Koeleman, E.R.A. Vos, G.A. Tramper-Stranders
69 [GO] 2021―Okt―13 A Practical Approach to SARS-CoV-2 Testing in a Pre and Post-Vaccination Era Sean C. Taylor
70 [GO] 2021―Sep―27 Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients. Bernadette Crescenzo-Chaigne, Vincent Enouf, Nicolas Escriou, Stephane Petres, Marie Noelle Ungeheuer, Jade Ghosn, et al. (+4)
71 [GO] 2021―Sep―24 Multi-center evaluation of Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV molecular point-of-care test John Sluimer, Gabriel Goderski, Sharon van den Brink, Maaike Broeders, Janette Rahamat-Langendoen, Euníce Then, et al. (+5)
72 [GO] 2021―Sep―02 Audit of vaccination status of health-care workers who tested positive for SARS-CoV-2 L. Berry, K. Jones, T. Robbins, N. Anderson, N. Morgan, K. Patel, et al. (+3)
73 [GO] 2021―Aug―18 Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera Judith Kannenberg, Carolin Schnurra, Nina Reiners, Reinhard Henschler, Raymund Buhmann, Thorsten Kaiser, et al. (+5)
74 [GO] 2021―Aug―15 Single base mutations in the nucleocapsid gene of SARS-CoV-2 affects amplification efficiency of sequence variants and may lead to assay failure Nathaniel Storey, Julianne R Brown, Rui P A Pereira, Denise M O'Sullivan, Jim F Huggett, Rachel Williams, et al. (+2)
75 [GO] 2021―Aug―09 Co-infection of SARS-CoV-2 and influenza viruses: a systematic review and meta-analysis Thi Loi Dao, Van Thuan Hoang, Philippe Colson, Matthieu Million, Philippe Gautret
76 [GO] 2021―Jul―03 Evaluation of alternative RNA extraction methods for detection of SARS-CoV-2 in nasopharyngeal samples using the recommended CDC primer-probe set Vinícius Pietta Perez, Wallace Felipe Blohen Pessoa, Bruno Henrique Andrade Galvão, Eduardo Sergio Soares Sousa, Naiara Naiana Dejani, Eloiza Helena Campana, et al. (+2)
77 [GO] 2021―Jun―19 Evaluation of the Genalyte Maverick SARS-CoV-2 Multi-Antigen Serology Panel Leslie J. Donato, Elitza S. Theel, Nikola A. Baumann, Amber R. Bridgeman, Joseph H. Blommel, Yanhong Wu, Brad S. Karon
78 [GO] 2021―Jun―14 Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland Lindsay McDonald, Helen Wise, Frauke Muecksch, Daniel Poston, Sally Mavin, Kate Templeton, et al. (+11)
79 [GO] 2021―Jun―14 Early detection of community acquired of SARS-CoV-2 lineage B.1.351 in Hong Kong Alan KL Tsang, Gannon CK Mak, Peter KC Cheng, Peter CW Yip, Ken HL Ng, Edman TK Lam, et al. (+2)
80 [GO] 2021―Jun―11 Characteristics of Children with Confirmed SARS-CoV-2 Infection in Indonesia Amin Soebandrio, Tina Kusumaningrum, Frilasita A. Yudhaputri, Sukma Oktavianthi, Safarina G. Malik, Khin Saw Aye Myint
81 [GO] 2021―Jun―09 Pediatric SARS-CoV-2 Seroprevalence During Mitigation Procedures in Southwestern Pennsylvania Glenn J. Rapsinski, Megan Culler Freeman, Ghady Haidar, Steven H Belle, Joanne H Hasskamp, Sarah E. Wheeler
82 [GO] 2021―Jun―06 Use of amplicon melt temperature to detect SARS-CoV-2 Lineage B.1.1.7 variant through the G28048T mutation in the ORF 8 gene. Richard S. Hale, Ashleigh Green, Emma Cunningham, Paul Joel
83 [GO] 2021―Mai―24 Evaluation of the Performance of the Quotient MosaiQTM COVID-19 Professional Use Microarray Assay for the Detection of Antibodies to SARS CoV-2 in a Clinical Setting José Vicario, Raquel Alenda-Asensi, Irene Lucea-Gallego, Javier Sánchez-Bonilla, Rebeca Saez, Reginald Clayton, et al. (+3)
84 [GO] 2021―Mai―16 Interpretation of single target positivity among SARS-CoV-2 RT-PCR result tests Honorine Fenaux, Théo Ghelfenstein-Ferreira, Maud Salmona, Nadia Mahjoub, Linda Feghoul, Sarah Maylin, et al. (+5)
85 [GO] 2021―Mai―11 Antigenic rapid test for SARS-CoV2 screening of individuals newly admitted to detention facilities: sensibility in an asymptomatic cohort Sara Mazzilli, Francesco Oliani, Andrea Restivo, Ruggero Giuliani, Lara Tavoschi, Roberto Ranieri
86 [GO] 2021―Mai―04 Comparative genomic analysis demonstrates that true reinfection following SARS-CoV-2 infection is possible Eamon O. Murchu, Sinead O'Neill, Paula Byrne, Cillian De Gascun, Michelle O'Neill, Máirín Ryan, Patricia Harrington
87 [GO] 2021―Mai―04 Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody Giovanna Moscato, Paola Mazzetti, Ersilia Lucenteforte, Alfredo Rosellini, Alice Cara, Paola Quaranta, et al. (+12)
88 [GO] 2021―Mai―03 Severe Acute Respiratory Syndrome Coronavirus 2 seroprevalence survey among 10,256 workers in Kuwait Haya Altawalah, Wadha Alfouzan, Rita Dhar, Walid Alali, Hamad Bastaki, Talal Al-Fadalah, et al. (+3)
89 [GO] 2021―Apr―14 Clinical Evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV Combination Test Grant Johnson, Arek Zubrzycki, Michele Henry, Charlene Ranadheera, Cindi Corbett, Adrienne F.A. Meyers, et al. (+2)
90 [GO] 2021―Apr―07 Field performance evaluation of the PanBio rapid SARS-CoV-2 antigen assay in an epidemic driven by the B.1.351 variant in the Eastern Cape, South Africa Oluwakemi Laguda Akingba, Kaitlin Sprong, Gert Marais, Diana Ruth Hardie
91 [GO] 2021―Apr―05 Comparative performances of seven quantitative Reverse-Transcription Polymerase Chain Reaction assays (RT-qPCR) for detecting SARS-CoV-2 infection in samples from individuals suspected of COVID-19 in São Paulo, Brazil Cláudio Tavares Sacchi, Maria Gisele Gonçalves, Ana Paula Silva Lemos, Samanta Cristine Grassi Almeida, Adele Caterino-de-Araujo, Lucila Okuyama Fukasawa
92 [GO] 2021―Apr―04 Comparison of Two Nucleic Acid Amplification Tests (NAATs) and Two Antigen Tests for Detection of SARS-CoV-2 from Upper Respiratory Specimens Peiting Kuo, Susan Realegeno, David T. Pride
93 [GO] 2021―Mrz―23 Is there a role for SARS-CoV-2 antigen testing in the post-containment strategy? Etienne Brochot
94 [GO] 2021―Mrz―23 Detection of the Novel SARS-CoV-2 European Lineage B.1.177 in Ontario, Canada Jennifer L. Guthrie, Sarah Teatero, Sandra Zittermann, Yao Chen, Ashleigh Sullivan, Heather Rilkoff, et al. (+9)
 [1] 

94 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec